| 2026-08-13 | Press release | Collegium Announces $50 Million Accelerated Share Repurchase Program |
| 2026-08-13 | 8-K | Form 8-K, Item 8.01 |
| 2026-08-06 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-06 | Press release | Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-05 | Deck | Investor presentation · Aug 2026 |
| 2026-07-23 | Press release | Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026 |
| 2026-07-20 | Press release | Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston |
| 2026-06-30 | 8-K | Form 8-K/A, Item 9.01 |
| 2026-06-05 | Press release | Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-05-15 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-12 | Press release | Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics |
| 2026-05-12 | 8-K | Form 8-K, Item 2.01 |
| 2026-05-07 | Press release | Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-05 | Deck | Q1 2026 Earnings Report |
| 2026-04-23 | Press release | Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-08 | Press release | Collegium to Participate in Upcoming Investor Conferences |
| 2026-04-07 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-07 | Proxy | Definitive proxy statement |
| 2026-03-19 | Press release | Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajecto |
| 2026-03-19 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-05 | Press release | Collegium to Present New Real-World Data at PainConnect 2026 |
| 2026-03-03 | Press release | Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Emp |
| 2026-03-02 | Press release | Collegium to Participate in Upcoming Investor Conferences |
| 2026-02-27 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-26 | Deck | 25-Q4 - Earnings Presentation FINAL · 2025 |
| 2026-02-26 | Press release | Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-23 | Press release | Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical |
| 2026-02-12 | Press release | Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on |
| 2026-01-15 | Press release | Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference |
| 2026-01-08 | Press release | Collegium Provides 2026 Financial Guidance and Business Update |
| 2026-01-08 | 8-K | Form 8-K, Item 7.01 |
| 2025-12-30 | 8-K | Form 8-K, Item 1.01 |
| 2025-11-06 | Press release | Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance |
| 2025-11-06 | 8-K | Form 8-K, Item 2.02 results |